Aligos Therapeutics, Inc.
Recent Filings
All 325 filings →| Form | Description | Date |
|---|---|---|
| 4 | — | Mar 11, 2026 |
| 4 | — | Mar 11, 2026 |
| 4 | — | Mar 11, 2026 |
| 4 | — | Mar 11, 2026 |
| S-8 | S-8 | Mar 5, 2026 |
| 10-K | 10-K | Mar 5, 2026 |
| 8-K | FORM 8-K | Mar 5, 2026 |
| 3 | — | Feb 19, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 11, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Nuechterlein Carole | — | Purchase | 7,933,601 @ $0.76 | 11,025,941 | Oct 25, 2023 |
| BLATT LAWRENCE | Chief Executive Officer | Award / Grant | 610,277 @ $0.76 | 1,847,575 | Oct 25, 2023 |
| Scopa James Paul | — | Award / Grant | 183,083 @ $0.76 | 183,083 | Oct 25, 2023 |
| Novo Holdings A/S | — | Purchase | 200,000 @ $15.00 | 2,614,563 | Oct 20, 2020 |